| Literature DB >> 26966180 |
Hisayo Nishida-Fukuda1, Ryoichi Araki2, Masachika Shudou3, Hidenori Okazaki2, Yasuko Tomono4, Hironao Nakayama5, Shinji Fukuda6, Tomohisa Sakaue6, Yuji Shirakata2, Koji Sayama2, Koji Hashimoto2, Michael Detmar7, Shigeki Higashiyama5, Satoshi Hirakawa8.
Abstract
Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), a type I transmembrane glycoprotein, is known as one of the most specific lymphatic vessel markers in the skin. In this study, we found that the ectodomain of LYVE-1 undergoes proteolytic cleavage, and this process produces soluble LYVE-1. We further identified the cleavage site for ectodomain shedding and generated an uncleavable mutant of LYVE-1. In lymphatic endothelial cells, ectodomain shedding of LYVE-1 was induced by vascular endothelial growth factor (VEGF)-A, an important factor for angiogenesis and lymphangiogenesis under pathological conditions. VEGF-A-induced LYVE-1 ectodomain shedding was mediated via the extracellular signal-regulated kinase (ERK) and a disintegrin and metalloproteinase (ADAM) 17. Wild-type LYVE-1, but not uncleavable LYVE-1, promoted migration of lymphatic endothelial cells in response to VEGF-A. Immunostaining analyses in human psoriasis skin lesions and VEGF-A transgenic mouse skin suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.Entities:
Keywords: ADAM; endothelial cell; extracellular signal-regulated kinase (ERK); hyaluronan; lymphangiogenesis; lymphatic endothelial hyaluronan receptor 1 (LYVE-1); psoriasis; shedding; skin; vascular endothelial growth factor (VEGF)
Mesh:
Substances:
Year: 2016 PMID: 26966180 PMCID: PMC4865900 DOI: 10.1074/jbc.M115.683201
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157